Methotrexate Transport and Resistance

References

• Fisher G.A. Defective transport of amethopterin (methotrexate) as a mechanism of resistance to the antimetabolite in L5178Y leukemic cells. Biochem Pharmacol. 1960; 11: 1233–1234
   Web of Science ®Google Scholar
• Goldman I.D., Lichtenstein N.S., Oliverio V.T. Carrier-mediated transport of the folic acid analogue, methotrexate, in LI210 leukemia. J Biol Chem 1968; 243: 5007–5017
   PubMed Web of Science ®Google Scholar
• Sirotnak F.M., Kurita F.M., Hutchison D.J. On the nature of a transport alteration detemining resistance to amethopterin in the LI210 leukemia. Cancer Res 1968; 28: 75–80
   PubMed Web of Science ®Google Scholar
• Henderson G.B., Zevely E.M. Transport of methotrexate in LI210 cells: effect of ions on the rate and extent of uptake. Arch Biochem Biophys 1980; 200: 149–55
   PubMed Web of Science ®Google Scholar
• Henderson G.B., Zevely E.M. Transport routes utilized by LI210 cells for the influx and efflux of methotrexate. J Biol Chem 1984; 259: 1526–1531
   PubMed Web of Science ®Google Scholar
• Henderson G.B., Zevely E.M. Characterization of the multiple transport routes for methotrexate in LI210 cells using phthalate as a model anion substrate. J Membr Biol 1985; 85: 263–8
   PubMed Web of Science ®Google Scholar
• Flintoff W.F., Essani K. Methotrexate-resistant Chinese hamster ovary cells contain a dihydrofolate reductase with an altered affinity for methotrexate. Biochemistry 1980; 18: 4321–1327
   Web of Science ®Google Scholar
• Flintoff W.F., Davidson S.V., Siminovitch L. Isolation and partial characterization of three methotrexate-resistant phenotypes from Chinese hamster ovary cells. Somatic Cell Genet 1976; 2: 245–261
   PubMedGoogle Scholar
• Ohnuma T., Lo R.J., Scanlon K.J., Kamen B.A., Ohnoshi T., Wolman S.R., Holland J.F. Evolution of methotrexate resistance of human acute lymphoblastic leukemia cells in vitro. Cancer Res 1985; 45: 1815–1822
   PubMed Web of Science ®Google Scholar
• Cowan K.H., Jolivet J. A methotrexate-resistant human breast cancer cell line with multiple defects, including diminished formation of methotrexate polyglutamates. J Biol Chem 1984; 259: 10793–10800
   PubMed Web of Science ®Google Scholar
• Dixon K.H., Trepel J.B., Eng S.C., Cowan K.H. Folate transport and the modulation of antifolate sensitivity in a methotrexate-resistant human breast cancer cell line. Cancer Communications 1991; 3: 357–365
   PubMedGoogle Scholar
• Schuetz J.D., Westin E.H., Matherly L.H., Pincus R., Swerdlow P.S., Goldman I.D. Membrane protein changes in an LI210 leukemia cell line with a translocation defect in the methotrexate-tetrahydrofolate cofactor transport carrier. J Biol Chem. 1989; 264: 16261–16261
   PubMed Web of Science ®Google Scholar
• Sirotnak F.M., Moccio D.M., Kellehcr L.E., Goutas L.J. Relative frequency and kinetic properties of transport-defective phenotypes among methotrexate-resistant LI210 clonal cell lines derived in vivo. Cancer Res 1981; 41: 4447–4452
   PubMed Web of Science ®Google Scholar
• Dixon K.H., Lanpher B.C., Chiu J., Kelley K., Cowan K.H. A novel cDNA restores reduced folate carrier activity and methotrexate sensitivity to transport deficient cells. J Biol Chem 1994; 269: 17–20
   PubMed Web of Science ®Google Scholar
• Williams F.R.M., Maurray R.C., Underhill T.M., Flintoff W.F. Isolation of a hamster cDNA clone coding for a function involved in methotrexate uptake. J Biol Chem 1994; 269: 5810–5816
   PubMed Web of Science ®Google Scholar
• Prasad P.D., Ramamoorthy S., Leibach F.H., Ganapathy V. Molecular cloning of the human placental folate transporter. Biochem Biophys Res Commun 1995; 206: 681–687
   PubMed Web of Science ®Google Scholar
• Williams F.M., Flintoff W.F. Isolation of a human cDNA that complements a mutant hamster cell defective in methotrexate uptake. J Biol Chem 1995; 270: 2987–2992
   PubMed Web of Science ®Google Scholar
• Wong S.C., Proefke S. A. A. B., Matherly L.H. Isolation of human cDNAs that restore methotrexate sensitivity and reduced folate carrier activity in methotrexate transport-deficient Chinese hamster ovary cells. J Biol Chem 1995; 270: 17468–17475
   PubMed Web of Science ®Google Scholar
• Moscow J.A., Gong M., He R., Sgagias M.K., Dixon K.H., Anzick S.L., Meltzer P.S., Cowan K.H. Isolation of a gene encoding a human reduced folate carrier(RFC1)and analysis of its expression in transport-deficient, methotrexate-resistant human breast cancer cells. Cancer Res 1995; 55: 3790–3794
   PubMed Web of Science ®Google Scholar
• Brigle K.E., Spinella M.J., Sierra E.E., Goldman I.D. Characterization of a mutation in the reduced folate carrier in a transport defective LI210 murine leukemia cell line. J Biol Chem 1995; 270: 22974–22979
   PubMed Web of Science ®Google Scholar
• Gong M.K., Yess J., Connolly T., Ivy S.P., Ohnuma T., Cowan K.H., Moscow J.A. Molecular mechanism of antifolate transport-deficiency in a methotrexate-resistant MOLT-3 cell line. Blood 1997; 89: 2494–2499
   PubMed Web of Science ®Google Scholar
• Moscow J.A., Connolly T., Myers T., Paull K., Cheng C.C., Cowan K.H. Reduced folate carrier gene expression in transfected and non-selected cell lines. Int J Cancer 1997; 72: 184–190
   PubMed Web of Science ®Google Scholar
• Alvarez M., Paull K., Monks A., Hose C., Lee J.-S., Weinstein J., Grever M., Bates S., Fojo T. Generation of a drug resistance profile by quantitation of mdr1 P-glycoprotein in the cell lines of the National Cancer Institute anticancer drug screen. J Clin Invest 1995; 95: 2205–2214
   PubMed Web of Science ®Google Scholar
• Gorlick R., Goker E., Trippet T., Stcinherz P., Elisseyeff Y., Mazumdar M., Flintoff W.F., Bertino J.R. Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expression. Blood 1997; 89: 1013–1018
   PubMed Web of Science ®Google Scholar
• Murray R.C., Williams F.M.R., Flintoff W.F. Structural organization of the reduced folate carrier gene in Chinese hamster ovary cells. J Biol Chem 1996; 271: 19174–19179
   PubMed Web of Science ®Google Scholar
• Tolner B., Roy K., Sirotnak F. Organization, structure and alternative splicing of the murine RFC-1 gene encoding a folate transporter. Gene 1997; 189: 1–7
   PubMed Web of Science ®Google Scholar
• Gong M., Cowan K.H., Moscow J.A. Analysis of transcription of multiple 5′ untranslated regions of the human Reduced Folate Carrier (RFC1) gene. Proc Am Assn Cancer Res 1997; 38: 1082
   Google Scholar
• Zhang L., Wong S.C., Matherly L.H. Upstream gene organization and transcript heterogeneity of he human reduced folate carrier. Proc Am Assn Cancer Res 1997; 38: 1084A
   Google Scholar
• Evans W.E., Crom W.R., Stewart C.F., Bowman W.P., Chen C.-H., Abromovitch M., Simone J.V. Methotrexate systemic clearance influences the probability of relapse in children with standard-risk acute lymphocytic leukaemia. Lancet 1984; 1: 359
   PubMed Web of Science ®Google Scholar
• Evans W.E., Crom W.R., Abromovich M., Dodge R., Look A.T., Bowman W.P., George S.L., Pui C.-H. Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia -identification between concentration and effect. New England J Med 1986; 314: 471–475
   PubMed Web of Science ®Google Scholar
• Camitta B., Mahoney D., Leventhal B., Lauer S.J., Shuster J.J., Adair S., Civin C., Munoz L., Steuber P., Strother D., Kamen B.A. Intensive intravenous methotrexate and mercaptopurinc treatment of high-risk non-T, non-B acute lymphoblastic leukemia-, a Pediatric Oncology Group study. J Clin Oncol 1994; 12: 1383–1390
   PubMed Web of Science ®Google Scholar
• Seidel H., Nygaard R., Moe P.J., Jacobsen G., Lindqvist B., Slordal L. On the prognostic value of systemic methoptrexate clearance in childhood acute lymphocytic leukemia. Leukemia Res 1997; 21: 429–434
   PubMed Web of Science ®Google Scholar
• Henderson G.B. Folate-binding proteins. Annu Rev Nutr. 1990; 10: 319–35
   PubMed Web of Science ®Google Scholar
• Elwood P.C. Molecular cloning and characterization of the human folate-binding protein cDNA from placenta and malignant tissue culture. J Biol Chem 1989; 264: 14893–14901
   PubMed Web of Science ®Google Scholar
• Lacey S.W., Sanders J.M., Rothberg K.G., Anderson R.G.W., Kamen B.A. Complementary DNA for the folate binding protein correctly predicts anchoring to the membrane by glycosyl-phosphatidylinositol. J Clin Invest 1989; 84: 715–720
   PubMed Web of Science ®Google Scholar
• Ratnam M., Marquardt H., Duhring J.L., Freisheim J.H. Homologous membrane folate binding proteins in human placenta: cloning and sequence of a cDNA. Biochemistry 1989; 28: 8249–8254
   PubMed Web of Science ®Google Scholar
• Sadasivan E., Rothenberg S.P. The complete amino acid sequence of a human folate binding protein from KB cells determined from the cDNA. J Biol Chem 1989; 264: 5806–5811
   PubMed Web of Science ®Google Scholar
• Jansen G., Westerhof G.R., Kathmann I., Rademaker B.C., Rijksen G., Schornagel J.H. Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance. Cancer Res 1989; 49: 2455–9
   PubMed Web of Science ®Google Scholar
• Chung K.N., Saikawa Y., Paik T.H., Dixon K.H., Mulligan T., Cowan K.H., Elwood P.C. Stable transfectants of human MCF-7 breast cancer cells with increased levels of human folate receptor exhibit increased sensitivity to antifolates. J Clin Invest 1993; 91: 1289–1294
   PubMed Web of Science ®Google Scholar
• Pinard M.-F., Jolivct J., Ratnam M., Kathmann I., Molthoff C, Westerhof R., Schornagel J.H., Jansen G. Functional aspects of membrane folate reeptors in human breast cancer cells with transport-related resistance to methotrexate. Cancer Chemother Pharmacol 1996; 38: 281–281
   PubMed Web of Science ®Google Scholar
• Dixon K., Mulligan T., Chung K., Elwood P., Cowan K. Effects of folate receptor expression following stable transfection into wild type and methotrexate transport-deficient ZR-75-1 human breast cancer cells. J Biol Chem 1992; 267: 24140–24147
   PubMed Web of Science ®Google Scholar
• Mauritz R.M., Kathmann I., Peters G.J., Pinedo H.M., Schornagel J.H., Priest D.G., Bunni M., Drori S., Assaraf Y.G., Jansen G. Characterization of a human CEM leukemia cell line with altered RFC-mediated transport of folic acid, reduced folates and tetrahydrofolate-based antifolates. Proc Am Assn Cancer Res 1997; 38: 654A
   Google Scholar
• Tse A., Brigle K., Moran R. Dominant mutations in the reduced folate carrier confer resistance to 5, 10-dideaza-tetrahydrofolate (DDATHF) by causing efficient transport of folic acid. Proc Am Assn Cancer Res 1997; 38: 1085A
   Google Scholar
• Henderson G.B., Strauss B.P. Characteristics of a novel transport system for folate compounds in wild-type and methotrexate-resistant LI210 cells. Cancer Res 1990; 50: 1709–14
   PubMed Web of Science ®Google Scholar
• Sierra E.E., Brigle K.E., Spinella M.J., Goldman I.D. pH dependence of methotrexate transport by the reduced folate carrier and the folate receptor in LI210 leukemia cells. Further evidence for a third route mediated at a low pH. Biochem Pharmacol 1997; 53: 223–231
   PubMed Web of Science ®Google Scholar
• Home D.W. Transport of folates and antifolates in liver. Proc Soc Exp Biol Medicine 1993; 202: 385–391
   PubMed Web of Science ®Google Scholar
• Galivan J. 5-Methyltetrahydrofolate transport by hepatoma cells and methotrexate-resistant sublines in culture. Cancer Res 1981; 41: 1757–62
   PubMed Web of Science ®Google Scholar
• Sclhub J., Rosenberg I.H. Folate transport in isolated brush border membrane vesicles from rat intestine. J Biol Chem 1981; 256: 4489–93
   PubMed Web of Science ®Google Scholar
• Said H.M., Ghishan F.K., Redha R. Folate transport by human intestinal brush-border membrane vesicles. Am J Physiol. 1987
   Google Scholar
• Schron C.M., Washington C.J., Blitzer B.L. The transmembrane pH gradient drives uphill folate transport in rabbit jejunum. Direct evidence for folate/hydroxyl exchange in brush border membrane vesicles. J Clin Invest 1985; 76: 2030–3
   PubMed Web of Science ®Google Scholar
• Mason J.B., Shoda R., Haskell M., Selhub J., Rosenberg I.H. Carrier affinity as a mechanism for the pH-depcndence of folate transport in the small intestine. Biochim Biophys Acta 1990; 1024: 331–5
   PubMed Web of Science ®Google Scholar
• Kumar C., Mover M., Dudeja P., Said H. A protein-tyrosine kinase-regulated, pH-dependent carrier-mediated uptake system for folate in human colonic epithelial cell line NCM460. J Biol Chem 1997; 272: 6226–6231
   PubMed Web of Science ®Google Scholar
• Chiao J., Roy K., Tolner B., Yang C.-H., Sirotnak F.M. RFC-1 gene expression regulates folate absorption in mouse small intestine. J Biol Chem 1997; 272: 11165–11170
   PubMed Web of Science ®Google Scholar
• Wong S.C., McQuade R., Proefke S.A., Bhushan A., Matherly L.H. Human K562 transfectants expressing high levels of reduced folate carrier but exhibiting low transport activity. Biochem Pharmacol 1997; 53: 199–206
   PubMed Web of Science ®Google Scholar
• Saito H., Masuda S., Inui K.-i. Cloning and functional characterization of a novel rat organic anion transporter mediating basolateral uptake of methotrexate in the kidney. J Biol Chem 1996; 271: 20719–20725
   PubMed Web of Science ®Google Scholar
• Deutsch J.C., Kolhouse J.F. Folate and methotrexate interactions in the rat kidney. Cancer Res 1989; 49: 5858–5862
   PubMed Web of Science ®Google Scholar
• Kullak-Ublick G.A., Hagenbuch B., Stieger B., Schteingart C.D., Hofmann A.F., Wolkoff A.W., Meier P.J. Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver. Gastroenterology 1995; 109: 1274–1282
   PubMed Web of Science ®Google Scholar
• Masuda M., I'izuka Y., Yamazaki M., Nishigaki R., Kato Y., Ni'inuma K., Suzuki H., Sugiyama Y. Methotrexate is excreted into the bile by canalicular Multispecific Organic Anion Transporter in rats. Cancer Res 1997; 57: 3506–3510
   PubMed Web of Science ®Google Scholar
• Moscow J.A., Schneider E.S., Ivy S.P., Cowan K.H. Multidrug resistance. Cancer chemotherapy and biological response modifiers, H.M. Pinedo, D.L. Longo, B.A. Chabner. Elsevier, New York 1997, Annual 17
   Google Scholar
• Leier I., Jedlitschky G., Buchholz U., Keppler D. Characterization of the ATP-dependent leukotricne C4 export carrier in mastozytoma cells. Eur J Biochem 1994; 220: 599–606
   PubMedGoogle Scholar
• Leier I., Jedlitschky G., Buchholz U., Cole S.P.C., Deeley R.G., Keppler D. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J Biol Chem 1994; 269: 27807–27810
   PubMed Web of Science ®Google Scholar
• Loe D.W., Almquist K.C., Deeley R.G., Cole S.P.C. Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. J Biol Chem 1996; 271: 9675–9682
   PubMed Web of Science ®Google Scholar
• Jedlitschky G., Leier I., Buchholz U., Center M., Keppler D. ATP-dependent transport of glutathione 5-conjugates by the multidrug resistance-associated protein. Cancer Res 1994; 54: 4833–4836
   PubMed Web of Science ®Google Scholar
• Leszczy:nska B.A., Pfaff E. Effect of depletion of cellular glutathione on methotrexate influx, efflux and retention in hepatocytes. Biochem Pharmacol 1985; 34: 1627–34
   PubMed Web of Science ®Google Scholar
• Kool M., de Haas M., Schefer G.L., Scheper R.J., van Eijk M.J.T., Juijn J.A., Baas F., Borst P. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the Multidrug Resistance-associated Protein gene (MRP1), in human cancer cell lines. Cancer Res 1997; 57: 3537–3547
   PubMed Web of Science ®Google Scholar
• Zhao R., Seither R., Brigle K.E., Sharina I.G., Wang P.J., Goldman I.D. Impact of overexpression of the reduced folate carrier (RFC1), an anion exchanger, on concentrative transport in murine LI210 leukemia cells. J Biol Chem 1997; 272: 21207–21212
   PubMed Web of Science ®Google Scholar
• Sirotnak F.M., Moccio D.M., Yang C.H. A novel class of genetic variants of the LI210 celll up-regulated for folate analogue transport inward. Isolation, characterization, and degree of metabolic instability of the system. J Biol Chem 1984; 259: 13139–13144
   PubMedGoogle Scholar
• Matherly L.H., Czajkowski C.A., Angeles S.M. Identification of a highly glycosylated methotrexate membrane carrier in K562 human erythroleukemia cells up-regulated for tetrahydrofolate cofactor and methotrexate transport. Cancer Res 1991; 51: 3420–6
   PubMed Web of Science ®Google Scholar
• Jansen G., Westerhof G.R., Jarmasewski M.J.A., Kathmann I., Rijksen G., Schornagel G. Methotrexate transport in variant human CCRF-CEM leukemia cells with elevated levels of the reduced folate carrier. J Biol Chem 1990; 265: 18272–18277
   PubMed Web of Science ®Google Scholar